0001213900-24-020087.txt : 20240305
0001213900-24-020087.hdr.sgml : 20240305
20240305152038
ACCESSION NUMBER: 0001213900-24-020087
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20240304
FILED AS OF DATE: 20240305
DATE AS OF CHANGE: 20240305
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: HSU ERIC C
CENTRAL INDEX KEY: 0001817867
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-39685
FILM NUMBER: 24719912
MAIL ADDRESS:
STREET 1: C/O INMED PHARMACEUTICALS INC.
STREET 2: SUITE 310 - 815 HASTINGS STREET
CITY: VANCOUVER
STATE: A1
ZIP: V6C 1B4
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: InMed Pharmaceuticals Inc.
CENTRAL INDEX KEY: 0001728328
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
ORGANIZATION NAME: 03 Life Sciences
IRS NUMBER: 000000000
STATE OF INCORPORATION: A1
FISCAL YEAR END: 0630
BUSINESS ADDRESS:
STREET 1: SUITE 310, 815 W. HASTINGS STREET
CITY: VANCOUVER
STATE: A1
ZIP: V6C 1B4
BUSINESS PHONE: (604) 669-7207
MAIL ADDRESS:
STREET 1: SUITE 310, 815 W. HASTINGS STREET
CITY: VANCOUVER
STATE: A1
ZIP: V6C 1B4
4
1
ownership.xml
OWNERSHIP DOCUMENT
X0508
4
2024-03-04
0
0001728328
InMed Pharmaceuticals Inc.
INM
0001817867
HSU ERIC C
C/O INMED PHARMACEUTICALS INC.
310-815 WEST HASTINGS ST.
VANCOUVER
A1
V6C1B4
BRITISH COLUMBIA, CANADA
0
1
0
0
Sr. VP, Pre-Clinical Res/Dev
0
Employee Stock Option (Expiration)
364.72
2024-03-04
4
H
0
309
0.00
D
2019-03-04
2024-03-04
Common shares
309
52545
D
Converted from the Canadian dollar exercise price of C$495 using an exchange rate of C$1.3572 = $US1.00
/s/ Eric A. Adams, attorney-in-fact for Mr. Eric C. Hsu
2024-03-05